Abstract

The iterative process of fluid biomarker development and validation in Alzheimer's disease

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Associations between cerebrospinal fluid biomarkers in individuals with normal cognitive function, mild cognitive impairment, or Alzheimer's disease by amyloid PET status: a cross-sectional survey
Jun Liu ... Bingdong Xu
The Lancet | VOL. 394
Jun Liu, et. al.Jun Liu ... Bingdong Xu
01 Oct 2019
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
... Andrew J Saykin
Alzheimer's & Dementia: The Journal of the Alzheimer's Association | VOL. 9
, et. al. ... Andrew J Saykin
07 Aug 2013
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Mark E Schmidt ... Danielle Harvey
Alzheimer's & Dementia | VOL. 8
Mark E Schmidt, et. al.Mark E Schmidt ... Danielle Harvey
03 Nov 2011
Fluid biomarkers in Alzheimer’s disease – current concepts
Christoffer Rosén ... Oskar Hansson
Molecular Neurodegeneration | VOL. 8
Christoffer Rosén, et. al.Christoffer Rosén ... Oskar Hansson
01 Jan 2013
View more papers

More From: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Paper Title
Journal
Date
Author
-
-
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | VOL. 16
--
01 Apr 2024
Issue Information
-
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | VOL. 16
--
01 Apr 2024
-
-
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | VOL. 16
--
01 Jan 2024
Issue Information
-
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | VOL. 16
--
01 Jan 2024
View more papers